Durata Therapeutics Inc (DRTX) Financial Statements (2023 and Earlier)

Company Profile

Business Address 200 SOUTH WACKER DRIVE
CHICAGO, IL 60606
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments59,73345,351
Cash and cash equivalents36,85332,257
Short-term investments22,88013,094
Prepaid expense643
Prepaid expense and other current assets5,845
Income taxes receivable1,971 
Deferred tax assets35781
Other undisclosed current assets718(781)
Total current assets:63,10051,195
Noncurrent Assets
Property, plant and equipment897981
Intangible assets, net (including goodwill)21,1035,811
Goodwill5,8115,811
Intangible assets, net (excluding goodwill)15,292 
Restricted cash and investments1,147852
Deferred costs419 
Other noncurrent assets3,816
Other undisclosed noncurrent assets9,66227,709
Total noncurrent assets:37,04435,353
TOTAL ASSETS:100,14486,548
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,27921,501
Accounts payable5,2758,618
Accrued liabilities7,11610,602
Employee-related liabilities2,279 
Taxes payable1,6092,281
Other undisclosed current liabilities(2,279) 
Total current liabilities:14,00021,501
Noncurrent Liabilities
Long-term debt and lease obligation25,000 
Long-term debt, excluding current maturities25,000 
Liabilities, other than long-term debt1,6761,117
Accrued income taxes1,3771,117
Other liabilities299 
Other undisclosed noncurrent liabilities20,88920,058
Total noncurrent liabilities:47,56521,175
Total liabilities:61,56542,676
Stockholders' equity
Stockholders' equity attributable to parent, including:38,57943,872
Common stock266184
Additional paid in capital207,754150,989
Other undisclosed stockholders' equity attributable to parent(169,441)(107,300)
Total stockholders' equity:38,57943,872
TOTAL LIABILITIES AND EQUITY:100,14486,548

Income Statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Operating expenses(57,225)(62,594)
Other operating expense, net(3,891) 
Other undisclosed operating income4,144125,174
Operating income (loss):(56,972)62,580
Nonoperating income
(Other Nonoperating income)
501 
Interest and debt expense(2,228) 
Income (loss) from continuing operations before equity method investments, income taxes:(58,699)62,580
Other undisclosed loss from continuing operations before income taxes(2,164)(41)
Income (loss) from continuing operations before income taxes:(60,863)62,539
Income tax expense(1,278) 
Income (loss) before gain (loss) on sale of properties:(62,141)62,539
Other undisclosed net loss (125,078)
Net loss available to common stockholders, diluted:(62,141)(62,539)

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net loss:(62,141)(62,539)
Comprehensive loss, net of tax, attributable to parent:(62,141)(62,539)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: